Package 50090-2575-3

{"route": ["ORAL"], "spl_id": "d399bfcb-81d0-4325-abda-9a39216e8529", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["69301126-c901-4d0d-9acb-91ba1a87cd21"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, FILM COATED in 1 BOTTLE (50090-2575-0)", "package_ndc": "50090-2575-0", "marketing_start_date": "20161028"}, {"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE (50090-2575-1)", "package_ndc": "50090-2575-1", "marketing_start_date": "20161215"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50090-2575-2)", "package_ndc": "50090-2575-2", "marketing_start_date": "20161031"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-2575-3)", "package_ndc": "50090-2575-3", "marketing_start_date": "20161031"}], "brand_name": "Valacyclovir", "product_id": "50090-2575_d399bfcb-81d0-4325-abda-9a39216e8529", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-2575", "generic_name": "Valacyclovir", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA203047", "marketing_category": "ANDA", "marketing_start_date": "20150525", "listing_expiration_date": "20271231"}